MEDICENNA THERAPEUTICS CORP (MDNAF)
Institutional ownership reported to the SEC as of Q4 2024, across 18 quarters.
1
Reporting holders
$200.4K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| ORG Partners LLC | $200.4K | 175,000 | 0.03% | 3q | +40.0%+$57.2K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2024 | 1 | $200.4K | 175,000 | 0 | 1 | 0 | 0.0% |
| Q3 2024 | 1 | $175.0K | 125,000 | 0 | 1 | 0 | 0.0% |
| Q2 2024 | 1 | $145.0K | 100,000 | 1 | 0 | 0 | 0.0% |
| Q4 2023 | 3 | $40.9K | 128,978 | 1 | 0 | 0 | 0.0% |
| Q3 2023 | 23 | $2.6M | 8,966,082 | 3 | 5 | 4 | 0.0% |
| Q2 2023 | 23 | $4.1M | 8,465,935 | 2 | 3 | 5 | 0.0% |
| Q1 2023 | 23 | $6.0M | 9,327,929 | 2 | 4 | 3 | 0.0% |
| Q4 2022 | 22 | $4.3M | 9,247,028 | 4 | 5 | 4 | 0.0% |
| Q3 2022 | 28 | $8.6M | 10,327,103 | 10 | 9 | 3 | 0.0% |
| Q2 2022 | 19 | $5.4M | 4,496,320 | 3 | 4 | 4 | 0.0% |
| Q1 2022 | 20 | $5.6M | 4,284,086 | 2 | 7 | 4 | 0.0% |
| Q4 2021 | 23 | $7.4M | 4,443,123 | 2 | 8 | 7 | 0.0% |
| Q3 2021 | 24 | $8.7M | 3,045,609 | 6 | 5 | 5 | 0.0% |
| Q2 2021 | 25 | $15.4M | 5,017,596 | 2 | 13 | 4 | 0.0% |
| Q1 2021 | 30 | $22.9M | 5,532,953 | 13 | 5 | 3 | 0.0% |
| Q4 2020 | 21 | $10.8M | 2,314,732 | 7 | 5 | 5 | 0.0% |
| Q3 2020 | 15 | $8.1M | 1,914,281 | 14 | 1 | 0 | 0.0% |
| Q2 2020 | 1 | $199.0K | 54,900 | 1 | 0 | 0 | 0.0% |